A radioimniunoassay (RIA) for the measurement of thyroglobulin in human serum was developed and factors that influence sensitivity were investigated. In a comparison of 3 different labeling procedures (chloramine T, iodogen, lactoperoxidase) iodogen-prepared tracer proved to be slightly superior with respect to sensitivity and stability. The shelf life of the tracer was improved by a protein-enriched buffer, which serves äs a radical scavenger. The binding kinetics of tracer to antibody at different temperature ranges were examined, and the most rapid and complete binding was found at room temperature. For the preparation of Standard curves, several artificial media were compared with thyroglobulin-free serum. Second antibody Separation was investigated and optimized. By employing sequential Saturation, sensitivity of 0.75 g/l (Bö-3 SD) and 50% intercept of less than 5 g/l were achieved. The results of RIA measurements of thyroglobulin in 142 patients with papillary and follicular thyroid carcinoma after thyroidectomy and 131 I treatment were compared with 131 I whole-body scans. The results confirmed that serum thyroglobulin is an early indicator of recurrency. 
Introduction
Scveral methods have been published for the thyroglobuiin assay (1) (2) (3) (4) . Radioimmunoassay has found wide application, and most assays employ the double antibody procedure.
For clinical use of the thyroglobuiin assay, sensitivity and precision seem to be most important (5, 6) . The assay is mainly employed in the follow-up of patients with differentiated thyroid carcinoma to detect early metastases and recurrencies. I3I I scans in connection with the measurement of serum thyroglobulin proved to be most reliable in the follow-up of those patients (7) (8) (9) (10) (11) . Some authors (6, (12) (13) (14) , have even proposed a reduction of scanning frequency after treatment if regul r thyroglobuiin measurements are performed. Since patients, after successful therapy of papillary and follicular thyroid carcinoma, should have no thyroglobulin in the serum (1,5, 8v9) , the occurrence of metastases and recurrencies may be detected earlier by sensitive assays (5) . Therefore, our aim was to study the factors important for the sensitivity of thyroglobulin RIA. Furthermore we wanted to show the advantages of thyroglobulin RIA in the follow-up of thyroid carcinoma. Patients with elevated serum thyroglobulin levels but no clinical evidence ( I3I I scan, ehest X-ray, palpation) of relapse were especially checked with a view to explaining the nature of the elevated thyroglobulin values.
Materials and Methods

Reagents
Human thyroglobulin was isolated from thyroid glands obtained at surgery and the purification was performed s previously described (4) .
For the preparation of Standards and for labeling, thyroglobulin was diluted in phosphate buffer, pH 7.4.
Other reagents (analytical grade, "pro analyse") were purchased from Merck AG, Darmstadt, FRG. I25 I was from Amersham Buchler GmbH, Braunschweig, FRG. Human serum albumin was from Behringwerke AG, Marburg/Lahn, FRG. All assays were performed in RIA-vials purchased from W. Sarstedt, N mbrecht, FRG.
Preparation of antiserum
Antisera to thyroglobulin were prepared in rabbits injected at 4-8 week intervals over a total of 12 months. A suitable antiserum with a high titer was obtained in rabbit no. l.
The antiserum was used at a dilution of 40,000-fold with phosphate buffer (0.06 mol/1, pH 7.4) containing human serum albumin (l g/l), sodium azide (l g/l) and EDTA (Titriplex III, 0.4 g/l) s diluent (working dilution). In addition, antiserum was purchased from UCB, Br ssel, Belgium.
lodination of thyroglobulin
Chloramine T method
Thyroglobulin was iodinated according to a modification of the method by Greenwood & Munter (15) : 20 μg of purified thyroglobulin, 18.5 MBqof I25 I (IMS 30, Amersham Buchler) and 10 μΐ of a lg/1 solution of chloramine T and 10 μΐ of phosphate buffer pH 7.4,0.5 mol/1 were mixed and reacted for 60 s. Then 50 μΐ of sodium metabisulfite (2.5 g/l) were added, immediately followed by ΙΟΟμΙ of dextran blue M r 200000 (10 g/l) and the mixture was applied on a Sephadex G25 column (0.9 cm x 30 cm) and eluted with a Tris/HCl/albumin buffer, pH 7.4. Fractions (20 drops) were collected in a LKB 7000 fraction collector, and chromatography was complete after collecting 40 ffactions. The first peak of radioactivity containing 125 I thyroglobulin was pooled. For convenience, and without alterations in the results, this column was replaced by a ready to use column (Pharmacia PD 10, Pharmacia GmbH, Freiburg, FRG) and elution was performed with Tris-HCl-buffer, pH 7.4, containing 50 mg/1 of human serurn albumin. A fraction collector is not necessary. Routinely, the tracer was diluted in the phosphate buffer used for diluting antiserum (1300 Bq/100 μ!).
Lactoperoxidase method
The lactoproxidase method for iodination was employed according to the procedure given by ΒΙΟ-RAD, Munich, FRG. The same amounts of thyroglobulin and iodine were used.
lodogen method
Labeling by use of iodogen was performed according to Wood (16) . lodogen (2 μg, purchased from Pierce, Eurpchemie B V, Rotterdam, NL) was dissolved in dichloromethane and pl ced in Eppendorf reaction vials. The dichloromethane was evaporated by N 2 and the tubes stored at -20 °C. lodination was performed with the same amounts of thyroglobulin and 125 I s described above. Incubation was carried out at room temperature for 10 min with constant mixing on an automatic mixing device. All iodinations were done under a well ventilated hood.
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Second antibody Separation
Second antibody (RD 17, anti-rabbit IgG from donkey) was from Deutsche Wellcome, Burgwedel, FRG. This second antibody was diluted 1:24 in the buffer, used for diluting first antibody.
Radioimmunoassay
Before radioimmunoassay, all samples were screened for interfering anti-thyroglobulin autoantibodies (2, 9, 17, 18) . Assay tubes and Standards were arranged in duplicate and 200 μΐ of Standards, controls and unknowns were added to the appropriate tubes, foU lowed by 100 μΐ of thyroglobulin antiserum (Ist antibody). The tubes were mixed, incubated s indicated (routinely 48 h), then 100 μΐ (1300 Bq) of I25 I labeled thyroglobulin was added to all tubes. Again the tubes were mixed and incubated for 48 h at room temperature. Then 100 μΐ of second antibody (donkey anti-rabbit IgG, RD 17, Deutsche Wellcome GmbH) was added and incubation continued for 2 h. The tubes were centrifuged for 10 min at 2000 g, at 4 °C to separate the bound and free fractions. The supernate was aspirated and disearded. The Sediment was washed with 600 μΐ of washing solution (9 g/l NaCl). Again the tubes were centrifuged for 10 min at 2000 g and the supernates again aspirated and disearded. The radioactivity of the sediment was counted for l min or until 10000 counts were accumulated. The nonspecific counts (average of one duplicate in each assay) were subtracted from the average of each duplicate determination of sample and Standard. The Standard curve was constrveted by plotting the 
Methodological results
lodination
The use of different labelling procedures resulted in high incorporation of I25 I with the chloramine T and the iodogen method and only low incorporation using the lactoperoxidase method. With iodogen and chloramine T, 83% of 125 I was incorporated into thyroglobulin and 45% with lactoperoxidase. Specific activities of 370-740 kBq^g were obtained.
Binding kinetics
The influence of time on the binding of 125 I labeled thyroglobulin tracer to the antiserum is illustrated in figure 1 .
As shown in figure l, iodogen-derived tracer resulted in better binding to the antiserum.
The binding of the tracer to the antibody is also influenced by temperature. Therefore, association kinetics were performed at 4-8°C (refrigerator), room temperature, 37 °C and 42 °C ( fig. 2 ).
As indicated in figure 2, incubation at room temperature resulted in the rnost rapid binding of tracer to the antibody. After 48 h, binding is nearly complete.
Comparison of the binding kinetics of figure 2 with those of figure l shows that tracers prepared by the iodogen method display the same binding kinetics. From these experiments it was decided to perform all further experiments at room temperature. The storage medium is of influence on the shelf life of the tracer. Protein is generally regarded s a radical scavenger. Storage of the tracer was therefore determined in routine buffer used for diluting antibodies and in a protein enriched buffer containing 10 g/1 human serurn albumin (tab. 2).
Tab. 2. Storage of I25 I thyroglobulin in phosphate buffer (0.06 mol/I, pH 7.4, containing I g/l human serum albumin, l g/l NaN-ι and 0.4 g/l EDTA) and in a protein-enriched buffer containing 10 g/l human scrum albumin. These data were obtained 16 days after labcling. 
Thyroglobulin Standards
Since it is difficult to obtain sufficient amounts of thyroglobulin-free serum, several artificial media were checked for their suitability s thyroglobulin Standard diluents (tab. 3). As shown in table 3, a phosphate b ffer (0.06 mol/1, pH 7.4) containing 10 g/1 human serum albumin, l g/l NaN 3 and 0.4 g/l EDTA yielded a count rate very near to that observed for thyroidectomized patient "C", a patient with previous medullary thyroid carcinoma, followed by more than 2 years free from the disease. Buffer compositions containing higher concentrations of human serum albumin (20 g/l or 40 /l) may be used, but this becomes more expensive. The medium for the Standard influenced the shape of the Standard curve. Thyroglobulin was therefore diluted in thyroglobulin-free serum and in the above mentioned buffer (10 g/l human serum albumin).
The results are illustrated in figure 4.
As seen from figure 4, the Standard curves are essentially superimposable.
Sensitivity and mode of incubation
Radioimmunoassays may be performed at equilibrium or with sequential Saturation. For the purpose of detecting low concentrations of thyroglobulin in serum, different modes of incubation were compared . 5).
It is apparent from figure 5 that sequential Saturation results in increased sensitivity. 90% of the tracer is bound at l μg/l, about 80% at 2 μg/I and about 20% at 20 μg/l.
Separation of bound and free ligand
Separation of bound and free I25 I thyroglobulin (tracer) was performed by a double-antibody System (donkey anti-rabbit IgG, RD 17, from Deutsche Wellcome GmbH). It was necessary to first optimize the amount of normal rabbit serum included in the antiserum dilution.
The second antibody (anti-rabbit IgG) was diluted 1:24. A precipitation experiment with 125 I thyroglobulin and increasing amounts of first antibody containing normal rabbit serum (4 or 6 ml/l) was performed ( fig. 6 ).
The addition of normal rabbit serum (6 ml/l) to the first antibody resulted in extremely high coefficients of Variation ( fig. 6 ), when 100 μΐ first antibody and 100 μΐ second antibody were used.
On the other hand, when 4 ml/l normal rabbit serum were added to the first antibody, and 100 μΐ first antibody and 100 μΐ second antibody were employed, a plateau of precipitated counts could be observed. Therefore, for further experiments 4 ml normal rabbit serum per liter first antibody solution were used. . Precipitation experiment with I25 I thyroglobulin and different amounts of first antibody containing normal rabbit serum (4 ml/l, Δ or 6 ml/l, O). The tube contained 200 μΐ thyroglob lin-free medium, 100 μΐ Ι25 Ι thyroglobulin (1300 Bq), 10-110 μΐ first antibody, and was incubated for 48 h at room temperature. Then 100 μΐ second antibody from donkey (1:24, purchased from Deutsche Wellcome GmbH) was added and incubation continued for another 2 h. All tubes were filled to 510 μΐ with Standard phosphate buffer. (0.06 mol/1, pH 7,4, containing l g/l human serum albumin, l g/I NaN·* and 0.4 g/l EDTA).
As second antibody precipitation might be influenced by the incubation temperature, different temperature ranges and incubation periods were investigated ( fig. 7) .
It is evident from figure 7 , that 2 h of incubation at room temperature was optimal.
Washing
After second antibody Separation, some laboratories wash the precipitate. The effect of washing on_ the second antibody Separation was investigated ( fig. 8 ).
As can be seen from figure 8, washing with 600 μΐ of 9 g/l NaCl solution reduces nonspecific binding and alters the shape of Standard curve at higher concentrations of unlabeled thyroglobulin. Therefore, washing was performed in further experiments because high nonspecific binding increases the imprecision of the results. 
Quality control
Parallelism
A serial dilution was made of 2 patient sera contain^· ing thyroglobulin of about 30 μg/l. Jhyroglobmlinfree serum was used s diluent. The 2 curves plotted s a function of the dilution display par llelism to the Standard curve ( fig. 9 ).
However, some discrepancies exist in the high concentration r nge above 32 
Recovery
An increasing amount of thyroglobulin was added to three serum samples with different thyroglobulin concentrations ( fig. 10 ). Figure 10 reveals that recovery is slightly higher than 100%.
Imprecision
Radioimmunoassays are known for their different precision at different concentrations of unlabeled ligand. For that reason, a precision profile was determined. The RIA was performed s usual (2d -f 2d + 2h at room temperature). For each Standard concentration, 12 ineasurements were performed. A typical U-shaped precision profile was obtained with eoefficients of Variation between 9% (l ^g/l), 3% (4 μg/l) and 5% (64 μg/l). The Standard deviation is less than 0.2 μξ/l 
Sensitivity
The sensitivity of the thyroglobulin RIA was evaluated using the usual statistical test: 11 measurements of the radioactivity of the bound fraction were obtained for the Standard without any detectable thyroglobulin. The mcan, the Standard deviation and the coefficient of Variation were then calculatcd. The minimum detectable concentration of thyroglobülin was then read off the Standard curve äs mean counts at zero concentration minus 3 Standard deviations. This gave a sensitivity of 0.75 g/l. RIA for this experiment was performed äs usual: 2d + 2d + 2h at room temperature.
Interassay coefficient of Variation
A control serum containing about 2.5 g/l of thyroglobülin was determined in 8 consecutively performed assays. An interassay Variation coefficient of 7.8% was obtained.
Clinical results
Patients 140 patients with papillary or follicular thyroid carcinoma and 2 patients with anaplastic thyroid carcinoma were selected in order to compare thyroglobülin radioimmunoassay with 131 I total body scans. Patients were only included if at least l scan and simultaneous serum sample without interfering antithyroglobulin autoantibodies were available.
All patients had undergone thyroidectomy äs well äs 131 I therapy and showed no residual thyroid tissue. There were 107 females and 35 males and mean age was 49.6 ± 13.8 years.
In 109 patients, clinical and radiological (ehest Xray, 131 I total body scan) investigation presented no signs of local or distant recurrence. 7 patients showed local relapse and 26 distant metastases.
Thyroglobülin radioimmunoassay and 131 I total body scan (tab. 4) As indicated in table 4, thyroglobülin RIA was superior to I31 I total body scan in 3 of 7 cases with local recurrence and in 9 of 26 patients with distant metastases. In contrast I31 I total body scan was superior to thyroglobülin RIA in 2 of 26 patients with distant metastases.
Of 109 patients without evidence of relapse by clinical and radiological (ehest X-ray f and 13I I total body scan) investigation, 17 showed elevated thyroglobü-lin serum levels (>6.4 g/l). (19) : 74 MBq 125 I and only 5 μ § thyroglobulin were used together with heavy oxidation of the protein (25 μg chloramine T oxidizing for 90 s).
Schlumberger & van Herle
Our iodinations were all performed with a ratio of 125 I to thyroglobulin which is 16-fold lower (18.5 MBq 125 I and 20 μg thyroglobulin). Using the chloramine T method, we only employ 10 μg chloramine T and oxidation was stopped after 60 s. For preparation of the Standard curve, bovine serum should not be used s Standard diluent, because it gives rise to high non-specific binding (14%).
Human serum devoid of thyroglobulin is the best Standard diluent, though it is difficult to obtain a sufficiently large pool. Therefore, different buffers were tested s substitute. A phosphate buffer with protein (human serum albumin, 10 g/l), sodium azide and EDTA yielded very similar binding and non-specific binding results compared with thyroglobulin-free serum ( fig. 5) . Bodlaender et al. (2) also employ phosphate-buffered saline solution (73 g/l bovme serum albumin) for preparation of Standard curve.
Sequential Saturation for the radioimmunoassay of thyroglobulin is mostly used (2, 3, 21, 26) . However, the reported incubation periods are much shorter (2, 3, 26, 27 ).
An attempt was also made to determine the optimal incubation temperature. From several experiments ( fig. 2, 5, 7) i t was decided to perform all incubation Steps at room temperature. Some authors, however, incubate (first and second incubation) at 4°C (3, 21) , others at 37 °C and 25 °C, respectively (2, 27), or 37 °C and room temperature, respectively (26) . As diagrams of binding kinetics have not been published by these authors, improved sensitivity may be obtained by prolongirig the first and second incubation period and by determiriation of the correct incubation temperature. In our assay, we use 2 days + 2 days at room temperature, It is evident from this evahiation that every double antibody System consisting of antiserum, carrief γ-globulin and second antibody has to be checked carefully s far s diluti h of antiserunij eoncentration of carrier γ-globulin and incubation temperature are concerned. Satisfactory results were obtained by adding 4ml normal r bbit serum to 11 of the first antibody solution (antiserum 1:40000). The necessary incubation time for second antibody from donkey (purchased by Deutsche Wellcome GmbH, diluted 1:24) was only 2 h at room tefnperature. In contrast to our findings, Benita et al. (3) reported that by use of second antibody from donkey an incubation period of 16-20 h is required (incubation temperature not mentioned).
There was parallelism between dilutions of the Standards and of patient sera using thyroglobulin-free serum s diluent. The recovery of added thyroglobulin was nearly 100% at concentrations ranging from 2 μg/l to 10 μg/l and slightly above 100% at higher concentrations.
The accuracy in the high concentration r nge (16 μg/l -64 μg/l) depended on washing the precipitate after second antibody Separation. According to van Herle et al. (1) washing the precipitate is not necessary. This discrepancy may be due to the different assay volumes used.
The precision profile of our assay is typically Ushaped, s is usual for radioimmunoassays.
Intraassay coefficient of Variation ranged from 3% to 9%. The interassay coefficient of Variation for a patient sample (thyroglobulin: 2.5 μ §/1) was 7.8%.
With the usual mode of incubation (2d + 2d + 2h at room temperature) a sensitivity of the assay of 0.75 μg/l was achfeved, and the 50% intercept ranged from 4 μg/l to 7 μg/l (antiserum 1:40000, labeling method: iodogen or chloramine T, incubation periods s usual). These findings contrast with the data previously published (tab. 5). The reference r nge is in accordance with the literature (8, 30) . However, lower normal human thyroglobulin ranges have been reported (13, 17, 21) .
For discrimination of patients in remission and those presenting local or distant metastases, a critical level (cut-off) of 6.4 μg/l was determined by statistical means (31) .
Definite evidence of local recurrence in our 7 patients was lways associated with elevated thyroglobulin serum levels (>6.4 μg/l). In 3 of these 7 instances the 131 I total body scans, however, were negative.
In 26 subjects with distant metastases, high serum thyroglobulin levels and positive I31 I scans were found in 13 (50%) cases. In 9 patients (34%) with elevated serum thyroglobulin the I31 I scans were negative. In 2 examinations (8%), positive 131 I scans were associated with thyroglobulin levels lower than 6.4 g/l. An additional 2 subjects (8%) showed both negative I31 I scans and low serum thyroglobulin values (<6.4 g/l).
Thus in 12 of 14 cases (86%) with negative 131 I scintigrams and definite recurrent thyroid carcinoma, the diagnosis was verified by the measurement of thyroglobulin.
In 92 of 109 patients (84%) presenting no clinical evidence of relapse, both serum thyroglobulin and 131 I scans were negative. However, in 17 of these 109 subjects elevated serum thyroglobulin levels were found. In contrast to other tumour marker tests we do not regard v these elevated thyroglobulin levels äs "false positive". According to our experience these patients represent a "high risk group" since 2 of these 17 subjects have since revealed recurrent thyroid carcinoma.
These findings suggest that a sensitive thyroglobulin radioimmunoassay is able to predict a relapse of thyroid carcinoma at a time when all other clinical data are still inconspicuous. Stimmarizing all the results, we can postulate: I therapy) but no further clinical evidence of relapse should be subjected to close and detailed screening.
4. However, in those cases where thyroglobulin autoantibodies are present, our thyroglobulin radioimmunoassay is not usable.
